NIH-funded research NIH-funded research

Vector control and malaria in the Asia-Pacific: improving surveillance and strategies to reduce transmission

Official title: Project-002

Funded at Walter and Eliza Hall Inst Medical Res · NIH-11523506 · Data updated 2026-11-12

A malaria-focused project in the Asia-Pacific (especially PNG and Cambodia) tests new ways to track insecticide resistance and improve vector control to help eliminate malaria.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionWalter and Eliza Hall Inst Medical Res
NIH-funded
Lab location1 site (Parkville, AUSTRALIA)
Project startApril 1, 2025
Project endMarch 31, 2029
Funding year2026
Award (this year)$247,996
NIH project number3U19AI129392-11S2
Project IDNIH-11523506 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are communities in malaria-endemic regions of PNG and nearby countries where vector control is being implemented and monitored.

Less likely to help

Patients in regions with different malaria dynamics or where vector-control strategies already exceed transmission thresholds may see limited direct benefit.

What this research studies

This project aims to strengthen malaria control by developing robust vector surveillance to map insecticide resistance and by evaluating how well current tools like bed nets perform in real-world settings. Researchers at WEHI in Australia will collaborate with regional partners to inform policy and strategy for malaria elimination in high-burden areas. The work will integrate field data, laboratory analysis, and policy insights to guide next-generation interventions against Plasmodium falciparum and Plasmodium vivax. The effort includes learning from elimination successes in Cambodia to tailor approaches for PNG and other less-advanced settings.

Why it matters

Potential benefit: If successful, the project could lead to more effective vector-control policies and interventions, accelerating malaria elimination efforts.

How similar studies have gone: Previous studies have shown that improved vector surveillance can inform better-tailored control measures, with varying success across settings.

Where this research is happening

  • Walter and Eliza Hall Inst Medical Res
    Parkville, Australia
    Active

Researchers

  • Principal investigator: Mueller, Ivo J — Walter and Eliza Hall Inst Medical Res
  • Study coordinator: Mueller, Ivo J

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.